Literature DB >> 17533213

Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease.

Erik R Dubberke1, Kimberly A Reske, Margaret A Olsen, Kathleen M McMullen, Jennie L Mayfield, L Clifford McDonald, Victoria J Fraser.   

Abstract

BACKGROUND: Colonization pressure has been identified as an important risk factor in the transmission of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus species, but the role of colonization pressure in the transmission of Clostridium difficile-associated disease (CDAD) is unclear. The purpose of this study was to evaluate CDAD pressure, a modified form of colonization pressure based on symptomatic CDAD cases, as a risk factor for CDAD.
METHODS: Retrospective cohort and nested case-control studies of patients admitted to Barnes-Jewish Hospital from January 1, 2003, through December 31, 2003. Univariate analysis and multivariate logistic regression models were used to evaluate the role of CDAD pressure as a risk factor for CDAD.
RESULTS: A total of 36 275 patients were included in the cohort, of which 382 had CDAD. The median CDAD pressure was higher for case patients than noncase patients (1.4 vs 0.3; P<.001), and only 1 patient with CDAD had a CDAD pressure of 0. In the nested case-control study, CDAD pressure remained an independent risk factor for CDAD after adjustment for demographics, severity of illness, medications received (chemotherapy, gastric acid suppressors, antidiarrheals or narcotics, and antibiotics), and abdominal procedures or surgery performed.
CONCLUSIONS: The results of this study suggest that CDAD pressure may be an independent risk factor for CDAD. Future studies that evaluate risk of CDAD should control for CDAD pressure.

Entities:  

Mesh:

Year:  2007        PMID: 17533213     DOI: 10.1001/archinte.167.10.1092

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  37 in total

Review 1.  Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition.

Authors:  Adebola O Ajao; Anthony D Harris; Mary-Claire Roghmann; J Kristie Johnson; Min Zhan; Jessina C McGregor; Jon P Furuno
Journal:  Infect Control Hosp Epidemiol       Date:  2011-05       Impact factor: 3.254

Review 2.  Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile.

Authors:  B Lynn Johnston; Elizabeth Bryce
Journal:  CMAJ       Date:  2009-03-17       Impact factor: 8.262

3.  Clostridium difficile: The evolving story.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-11       Impact factor: 2.471

4.  Measurement and Impact of Staphylococcus aureus Colonization Pressure in Households.

Authors:  Marcela Rodriguez; Patrick G Hogan; Melissa Krauss; David K Warren; Stephanie A Fritz
Journal:  J Pediatric Infect Dis Soc       Date:  2013-02-11       Impact factor: 3.164

5.  Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection.

Authors:  Kevin A Brown; Nagham Khanafer; Nick Daneman; David N Fisman
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

6.  Epidemiology of Clostridium difficile-associated disease in internal medicine wards in northern Italy.

Authors:  Luca Mellace; Dario Consonni; Gaia Jacchetti; Marta Del Medico; Riccardo Colombo; Marta Velati; Simone Formica; Maria Domenica Cappellini; Silvana Castaldi; Giovanna Fabio
Journal:  Intern Emerg Med       Date:  2012-01-17       Impact factor: 3.397

7.  Michigan Clostridium difficile hospital discharges: frequency, mortality, and charges, 2002-2008.

Authors:  Kerrie E VerLee; Jennie L Finks; Melinda J Wilkins; Eden V Wells
Journal:  Public Health Rep       Date:  2012 Jan-Feb       Impact factor: 2.792

8.  Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease?

Authors:  Erik R Dubberke; Kathleen M McMullen; Jennie L Mayfield; Kimberly A Reske; Peter Georgantopoulos; David K Warren; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2009-04       Impact factor: 3.254

Review 9.  A review of the economics of treating Clostridium difficile infection.

Authors:  Kari A Mergenhagen; Amy L Wojciechowski; Joseph A Paladino
Journal:  Pharmacoeconomics       Date:  2014-07       Impact factor: 4.981

10.  Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.

Authors:  Annie-Claude Labbé; Louise Poirier; Duncan Maccannell; Thomas Louie; Michel Savoie; Claire Béliveau; Michel Laverdière; Jacques Pépin
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.